DPV-001 an autophagosome-enriched cancer vaccine in phase II clinical trials contains 25 putative cancer antigens, DAMPS, HSPS and agonists for TLR 2, 3, 4, 7 and 9

समान संसाधन

• Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer
  द्वारा: van de Ven, Rieneke, और अन्य
  प्रकाशित: (2018)
• Autophagy-assisted antigen cross-presentation: Autophagosome as the argo of shared tumor-specific antigens and DAMPs
  द्वारा: Yi, Yongxiang, और अन्य
  प्रकाशित: (2012)
• Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC
  द्वारा: Hilton, Traci, और अन्य
  प्रकाशित: (2014)
• Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC
  द्वारा: Sanborn, Rachel, और अन्य
  प्रकाशित: (2015)
• A case of mistaken identity: HSPs are no DAMPs but DAMPERs
  द्वारा: van Eden, Willem, और अन्य
  प्रकाशित: (2011)